Clinical Trial Update: Topical Tranexamic Acid for Bilateral Breast Reduction Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating topical tranexamic acid to reduce hematoma after bilateral breast reduction surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Reduction Surgery-related Complications
• Hematoma Postoperatively

Drugs mentioned

• Tranexamic acid (topical) (tranexamic acid)

Snippet

Sponsor: McMaster University | Conditions: Hematoma Postoperative, Tranexamic Acid | Phase 3 | Status: UNKNOWN